As a modulator of the NF-kB pathway, SHARPIN up-regulation promotes cell proliferation, migration, invasion and chemoresistance in prostate cancer by affecting the downstream targets survivin and livin [45]. Here, BIRC7 is linked to prostate carcinoma.